Abstract
Bariaa A. Khalil, Noha Mousaad Elemam, Azzam A. Maghazachi
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
Temporal profiling of plasma cytokines, chemokines and growth factors from mild, severe and fatal COVID-19 patients
10.1038/s41392-020-0211-1 · 2020
A novel coronavirus from patients with pneumonia in China, 2019
10.1056/nejmoa2001017 · 2020
10.1016/s0140-6736(20)30183-5
10.1016/s0140-6736(20)30183-5
10.1172/jci137244
10.1172/jci137244
10.1093/nsr/nwaa041
10.1093/nsr/nwaa041
Immune response, inflammation, and the clinical spectrum of COVID-19
10.3389/fimmu.2020.01441 · 2020
10.1038/s41423-020-0402-2
10.1038/s41423-020-0402-2
10.1016/j.clim.2020.108448
10.1016/j.clim.2020.108448
10.1038/s41577-020-0311-8
10.1038/s41577-020-0311-8
10.1126/science.abb8925
10.1126/science.abb8925
10.1189/jlb.1102577
10.1189/jlb.1102577
10.1038/nri980
10.1038/nri980
10.4049/jimmunol.164.8.4048
10.4049/jimmunol.164.8.4048
Expression and regulation of chemokine receptors in human natural killer cells
10.1182/blood.v97.2.367 · 2001
C-C chemokines induce the chemotaxis of NK and IL-2-activated NK cells. Role for G proteins
10.4049/jimmunol.153.11.4969 · 1994
Interferon-inducible protein-10 and lymphotactin induce the chemotaxis and mobilization of intracellular calcium in natural killer cells through pertussis toxin-sensitive and -insensitive heterotrimeric G-proteins
10.1096/fasebj.11.10.9271361 · 1997
10.1016/s0966-842x(03)00157-4
10.1016/s0966-842x(03)00157-4
10.1002/eji.1830260207
10.1002/eji.1830260207
10.1084/jem.20021522
10.1084/jem.20021522
10.1084/jem.187.1.1
10.1084/jem.187.1.1
10.1097/00130832-200312000-00008
10.1097/00130832-200312000-00008
10.1016/j.virol.2005.09.024
10.1016/j.virol.2005.09.024
Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults
10.1016/j.jcv.2017.03.003 · 2017
Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease
10.1089/jir.2010.0131 · 2011
Serum IP-10 as a biomarker of human rhinovirus infection at exacerbation of COPD
10.1378/chest.09-1541 · 2010
Association of interleukin-8 and neutrophils with nasal symptom severity during acute respiratory infection
10.1002/jmv.24042 · 2015
10.1002/eji.1830271004
10.1002/eji.1830271004
Intrahepatic IP-10 mRNA and plasma IP-10 levels as response marker for HBeAg-positive chronic hepatitis B patients treated with peginterferon and adefovir
10.1016/j.antiviral.2016.05.002 · 2016
Plasma IP-10 is associated with rapid disease progression in early HIV-1 infection
10.1089/vim.2012.0011 · 2012
High IP-10 levels decrease T cell function in HIV-1-infected individuals on ART
10.1189/jlb.3a0414-232rr · 2014
10.1016/s0002-9440(10)65068-7
10.1016/s0002-9440(10)65068-7
10.1128/jvi.75.2.878-890.2001
10.1128/jvi.75.2.878-890.2001
Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease
10.1111/j.1572-0241.2002.07054.x · 2002
10.1172/jci9232
10.1172/jci9232
10.1126/science.7667639
10.1126/science.7667639
Expression of macrophage inflammatory protein (MIP)-1α, MIP-1β, and RANTES genes in lymph nodes from HIV+ individuals: correlation with a Th1-type cytokine response
10.1046/j.1365-2249.1998.00555.x · 1998
10.1126/science.270.5243.1811
10.1126/science.270.5243.1811
10.1126/science.272.5270.1955
10.1126/science.272.5270.1955
Chemokine receptor-specific antibodies in cancer immunotherapy: achievements and challenges
10.3389/fimmu.2015.00012 · 2015
The expanding therapeutic perspective of CCR5 blockade
10.3389/fimmu.2017.01981 · 2018
10.1038/s41577-020-0331-4
10.1038/s41577-020-0331-4 · doi-reference
Functional roles of CCL5/RANTES in liver disease
10.1016/j.livres.2020.01.002 · doi-reference
RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS
10.1038/srep18424 · doi-reference
10.1101/2020.05.02.20084673
10.1101/2020.05.02.20084673 · doi-reference
10.1038/nm1303
10.1038/nm1303 · doi-reference
10.1371/journal.ppat.1002098
10.1371/journal.ppat.1002098 · doi-reference
10.1136/gutjnl-2015-310514
10.1136/gutjnl-2015-310514 · doi-reference
10.4049/jimmunol.180.4.2562
10.4049/jimmunol.180.4.2562 · doi-reference
Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models
10.4049/jimmunol.163.4.2193 · doi-reference
10.1073/pnas.0334864100
10.1073/pnas.0334864100 · doi-reference
Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes
10.1182/blood.v78.4.1112.1112 · doi-reference
10.3390/ijms20112785
10.3390/ijms20112785 · doi-reference
10.1590/s1679-45082015rb3438
10.1590/s1679-45082015rb3438 · doi-reference
Two distinct immunopathological profiles in autopsy lungs of COVID-19
10.1038/s41467-020-18854-2 · doi-reference
10.1038/s41591-020-0901-9
10.1038/s41591-020-0901-9 · doi-reference
Should we stimulate or suppress immune responses in COVID-19?Cytokine and anti-cytokine interventions
10.1016/j.autrev.2020.102567 · doi-reference
10.1016/j.coviro.2011.10.026
10.1016/j.coviro.2011.10.026 · doi-reference
10.1016/j.cell.2020.05.006
10.1016/j.cell.2020.05.006 · doi-reference
10.1016/j.immuni.2014.09.007
10.1016/j.immuni.2014.09.007 · doi-reference
10.1038/s41590-018-0260-6
10.1038/s41590-018-0260-6 · doi-reference
Lymphoid follicle cells in chronic obstructive pulmonary disease overexpress the chemokine receptor CXCR3
10.1164/rccm.200807-1089oc · doi-reference
10.1038/nm1091
10.1038/nm1091 · doi-reference
10.1172/jci141054
10.1172/jci141054 · doi-reference
Characterization of beta-R1, a gene that is selectively induced by interferon beta (IFN-beta) compared with IFN-alpha
10.1074/jbc.271.37.22878 · doi-reference
10.1084/jem.187.12.2009
10.1084/jem.187.12.2009 · doi-reference
Monoclonal antibody against CXCL-10/IP-10 ameliorates influenza A (H1N1) virus induced acute lung injury
10.1038/cr.2013.25 · doi-reference
10.1016/s1359-6101(97)00015-4
10.1016/s1359-6101(97)00015-4 · doi-reference
10.1164/rccm.201203-0508oc
10.1164/rccm.201203-0508oc · doi-reference
Regulation of pulmonary fibrosis by chemokine receptor CXCR3
10.1172/jci16861 · doi-reference
10.4049/jimmunol.162.6.3549
10.4049/jimmunol.162.6.3549 · doi-reference
Effects of the TLR2 agonists MALP-2 and Pam3cys in isolated mouse lungs
10.1371/journal.pone.0013889 · doi-reference
10.1016/j.cell.2008.02.043
10.1016/j.cell.2008.02.043 · doi-reference
10.3390/biom5031386
10.3390/biom5031386 · doi-reference
10.1158/0008-5472.can-05-3842
10.1158/0008-5472.can-05-3842 · doi-reference
The role of CXCR2 in systemic neovascularization of the mouse lung
10.1152/japplphysiol.00037.2007 · doi-reference
Humanized monoclonal antibody against the chemokine CXCL-8 (IL-8) effectively prevents acute lung injury
10.1016/j.intimp.2009.11.005 · doi-reference
10.1073/pnas.0402090101
10.1073/pnas.0402090101 · doi-reference
10.1124/jpet.106.119040
10.1124/jpet.106.119040 · doi-reference
10.1128/jvi.75.14.6450-6459.2001
10.1128/jvi.75.14.6450-6459.2001 · doi-reference
10.1074/jbc.273.17.10095
10.1074/jbc.273.17.10095 · doi-reference